References
- Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis work group. J Am Acad Dermatol. 2014;70(2):338–351.
- Langan S, Irvine A, Weidinger S. Atopic dermatitis. Lancet. 2020;396(10247):345–360.
- Katoh N, Ohya Y, Ikeda M, et al. Clinical practice guidelines for the management of atopic dermatitis 2018. J Dermatol. 2019;46(12):1053–1101.
- Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–132.
- Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based european guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682.
- Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technology Assessment. 2000;4(37):1–191.
- Nakahara T, Morimoto H, Murakami N, et al. Mechanistic insights into topical tacrolimus for the treatment of atopic dermatitis. Pediatr Allergy Immunol. 2018;29(3):233–238.
- Czarnecka-Operacz M, Jenerowicz D. Topical calcineurin inhibitors in the treatment of atopic dermatitis – an update on safety issues. J Dtsch Dermatol Ges. 2012;10(3):167–172.
- Wollenberg A, Reitamo S, Girolomoni G, et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy. 2008;63(7):742–750.
- European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the scorad index. Dermatology. 1993;186(1):763–769.
- Hanifin J, Rajka D. Diagnostic features of atopic dermatitis. Acta Dermato-Venereologica. 1980;92(Suppl):44–47.
- R Core Team 2019. “R: A Language and Environment for Statistical Computing.” Vienna, Austria: R Foundation for Statistical Computing. Available from: https://www.r-project.org/
- Wickham H. 2016. “ggplot2: Elegant Graphics for Data Analysis.” Springer-Verlag New York. Available from: https://ggplot2.tidyverse.org/
- Hanifin JM, Ling MR, Langley R, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. Journal of the American Academy of Dermatology. 2001;44(1):S28–S38.
- Paller AS, Tom WL, Lebwohl MG, et al. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol. 2016;75(3):494–503.e6.
- Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci. 2010;58(1):1–7.
- Iannone M, Tonini G, Janowska A, et al. Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review. Curr Med Res Opin. 2021;37(8):1295–1301.
- Kataoka Y. Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis. J Dermatol. 2014;41(3):221–229.